We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IMU market cap is 292.79M. The company's latest EPS is AUD -0.0204 and P/E is -1.96.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 4.21M | 7.28M | 12.97M | 11.78M | 4.97M |
| Operating Income | -10.67M | -18.39M | -37.7M | -39.52M | -140.73M |
| Net Income | -10.51M | -18.46M | -37.87M | -37.92M | -149.68M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 65.21M | 71.81M | 147.61M | 197.06M | 151.4M |
| Total Liabilities | 5.4M | 6.79M | 8.9M | 7.44M | 33.14M |
| Total Equity | 59.81M | 65.02M | 138.71M | 189.63M | 118.26M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -10.44M | -13.28M | -30.85M | -31.47M | -101.73M |
| Investing | -1.21M | -5.33M | -221k | 1.7M | -7.25M |
| Financing | 22.71M | 17.99M | 101.34M | 82.98M | 49.43M |
| Market Cap | 292.79M |
| Price to Earnings Ratio | -1.96 |
| Price to Sales Ratio | 57.14 |
| Price to Cash Ratio | 3.15 |
| Price to Book Ratio | 2.48 |
| Dividend Yield | - |
| Shares Outstanding | 7.32B |
| Average Volume (1 week) | 19.59M |
| Average Volume (1 Month) | 17.5M |
| 52 Week Change | -54.55% |
| 52 Week High | 0.13 |
| 52 Week Low | 0.039 |
| Spread (Intraday) | 0 (2.44%) |
| Company Name | Imugene Limited |
| Address |
level 3 melbourne, victoria 3053 |
| Website | https://www.imugene.com |
| Industry | biotechnology animal & plant (C36) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
